Category talk:Designer drugs

There should be two categories out of this one; grey market pharmaceuticals; e.g. 'street designer drugs' made for no other purpose than intoxication, and Category:Research Chemicals, made for academic publishings and neuro-biological ligand research et al. Nagelfar (talk) 00:05, 27 April 2015 (UTC)[reply]

Disagree. Most "street designer drugs" were once developed by pharmaceutical companies for the exact same reasons of your proposed "research chemicals" category. Where do you cut the line, once the substance appears on the grey market? Also "research chemicals" and "designer drugs" are pretty much synonyms these days. Aethyta (talk) 06:04, 28 April 2015 (UTC)[reply]

Well we'll have to agree to disagree. Many ligands are used primarily, if not only, in research; those that labs can get through Sigma Aldrich et cetera., and then there are those created with the intent of legal loopholes, or to be "safer" for recreational (consistent) usage like methoxetamine. I think the line is rather clear, only in some areas does it become fuzzy. IPT for example, is almost exclusively a research radio-ligand, and if that's the reason it comes on the grey market (because of high quantities being produced for legitimate academic research consumers, and someone gets a hold on those left-over batches to distribute to recreational users, that's a research chemical that is used as a designer drug, IMHO). I could basically separate them by how useful they are to what purpose. Whether for research, or because of analog-laws or toxicity reduction. Nagelfar (talk) 21:42, 28 April 2015 (UTC)[reply]